Age Related Macular Degeneration
Phase 2 gene boosters protect the eye from photo-oxidative damage
Published in Gene Therapy Weekly, September 23rd, 2004
According to recent research published in the journal Proceedings of the National Academy of Sciences of the United States of America, "the retinal pigment epithelial cell (RPE cell) layer protects the photoreceptors of the retina against oxidative stress. The decline of this capacity is believed to be a major factor in the impairment of vision in age-related macular degeneration. Exposure of human adult RPE cells to UV light at predominantly 320-400 nm (UVA light) in the presence of all-trans-retinaldehyde results in photo-oxidative cytotoxicity."
"Significant protection of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-09-23)
More Articles from Gene Therapy Weekly
- Cancer Therapy
The C-terminal domain of tenomodulin has antiangiogenic properties - Pancreatic Cancer
The Wilms tumor gene is overexpressed in pancreatic ductal adenocarcinoma - Renal Cancer
von Hippel-Lindau promotes the self-destruction of renal carcinoma cells - Stem Cell Research
ABC transporter inhibitors enhance hematopoietic progenitor cell transduction - Suicide Gene Therapy
Mutant cytosine deaminase is an effective prodrug converter - Antisense Technology
Novel substitutions confer stability to oligonucleotides - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
